OncoSec Medical Inc
Biotechnology
Healthcare
ONCS
1.79 M shares
NASDAQ US
traded
30 Mar 2023
listed
yes
open
2.24
52 week high
7.92
high
2.32
52 week low
1.35
low
2.15
growth
-46.14 %
previous Close
2.23
P/E ratio
-0
market cap
6.74 M
div yield
0
usd
Oct 2022
qoq
revenue
0.00 %
net incoming
-8.06 M
1.89 %
eps
-4.50 %
2.60 %
eps surprise
8.16 %
net profit margin
-806139800.00 %
0.00 %
operating incoming
-7.31 M
10.15 %
net change in cash
-6.57 M
8.47 %
cash on hand
5.73 M
-53.42 %
cost of revenue
0.00 %
top top